These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7530176)

  • 21. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells.
    Hsi BL; Hunt JS; Atkinson JP
    J Reprod Immunol; 1991 Apr; 19(3):209-23. PubMed ID: 1713970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.
    Tedesco F; Narchi G; Radillo O; Meri S; Ferrone S; Betterle C
    J Immunol; 1993 Aug; 151(3):1562-70. PubMed ID: 7687635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The change of membrane complement regulatory protein in chorion of early pregnancy.
    Nishikori K; Noma J; Hirakawa S; Amano T; Kudo T
    Clin Immunol Immunopathol; 1993 Nov; 69(2):167-74. PubMed ID: 7691457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.
    Holmes CH; Simpson KL; Wainwright SD; Tate CG; Houlihan JM; Sawyer IH; Rogers IP; Spring FA; Anstee DJ; Tanner MJ
    J Immunol; 1990 Apr; 144(8):3099-105. PubMed ID: 1691227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical studies of human uteroplacental tissues from first-trimester spontaneous abortion.
    Hill JA; Melling GC; Johnson PM
    Am J Obstet Gynecol; 1995 Jul; 173(1):90-6. PubMed ID: 7631733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 30. Localization of the complement regulatory proteins in the normal human kidney.
    Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S
    Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The control of hyperacute rejection by genetic engineering of the donor species.
    White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
    Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunobiology of the human placental trophoblast.
    Johnson PM
    Exp Clin Immunogenet; 1993; 10(2):118-22. PubMed ID: 8251180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
    Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
    Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
    [No Abstract]   [Full Text] [Related]  

  • 36. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.
    Davitz MA; Low MG; Nussenzweig V
    J Exp Med; 1986 May; 163(5):1150-61. PubMed ID: 2422313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the complement regulatory protein CD59 on human spermatozoa: characterization and role in gametic interaction.
    Fenichel P; Cervoni F; Hofmann P; Deckert M; Emiliozzi C; Hsi BL; Rossi B
    Mol Reprod Dev; 1994 Jul; 38(3):338-46. PubMed ID: 7522480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
    J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.